| Symbol | CPHI |
|---|---|
| Name | CHINA PHARMA HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | Asia |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | SECOND FLOOR,NO. 17, JINPAN ROAD, HAIKOU, 570216, China |
| Telephone | +86 898 - 6681-1730 |
| Fax | — |
| — | |
| Website | https://www.chinapharmaholdings.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001106644 |
| Description | China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the Peoples Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others. Additional info from NASDAQ: |
(99% Neutral) CHINA PHARMA HOLDINGS, INC. (CPHI) Announces Business Combination
Read more(99% Neutral) China Pharma Holdings Inc. (CPHI) Announces Business Combination
Read more(99% Neutral) CHINA PHARMA HOLDINGS, INC. (CPHI) Announces Business Combination
Read more(99% Neutral) CHINA PHARMA HOLDINGS, INC. (CPHI) Announces Business Combination
Read moreNew Form PRE 14A - CHINA PHARMA HOLDINGS, INC. Filed: 2025-11-04 AccNo: 0001213900-25-106092 Size: 218 KB
Read moreNew Form 10-K - CHINA PHARMA HOLDINGS, INC. Filed: 2025-03-31 AccNo: 0001213900-25-026280 Size: 6 MB
Read more(99% Neutral) CHINA PHARMA HOLDINGS, INC. (CPHI) Announces Business Combination
Read more